Brief: SCYNEXIS Reports Q2 Loss Per Share Of $0.31
Aug 15 (Reuters) - SCYNEXIS Inc SCYX.O :
* SCYNEXIS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES CORPORATE UPDATE
* Q2 SALES $1.3 MILLION
* Q2 LOSS PER SHARE $0.31
* SAYS CASH AND CASH EQUIVALENTS TOTALED $118.7 MILLION ON
JUNE 30
VERSUS $104.5 MILLION IN CASH AND CASH EQUIVALENTS ON DECEMBER
31, 2021
Source text for Eikon: ID:nGNX9x09ct
Further company coverage: SCYX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Scynexis
See all newsBrief: Scynexis Announces Phase 1 Study Results For Scy-770, A Novel, Highly Selective, Oral Direct Ampk Activator For The Treatment Of Autosomal Dominant Polycystic Kidney Disease
Brief: Scynexis Announces Appointment Of Sanjay Subramanian As Chief Financial Officer
Scynexis Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Scynexis Q2 swings to profit on warrant adjustment; advances drug studies
Scynexis Inc Expected To Post A Loss Of 51 Cents A Share: Earnings Preview